We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$578B
AUM Growth
+$59.6B
Cap. Flow
+$35.2B
Cap. Flow %
6.08%
Top 10 Hldgs %
31.21%
Holding
15,826
New
1,745
Increased
6,428
Reduced
6,082
Closed
1,423

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$830M
2
UNH icon
UnitedHealth
UNH
+$769M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$691M
4
AMZN icon
Amazon
AMZN
+$654M
5
BAC icon
Bank of America
BAC
+$634M

Sector Composition

Rank Sector Weight
1 Healthcare 3.13%
2 Technology 2.97%
3 Financials 2.19%
4 Consumer Discretionary 2.09%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENG
15751
DELISTED
ENGlobal Corp
ENG
-15,008
Closed -$19.1K
GENE
15752
CALL
DELISTED
Genetic Technologies Ltd.
GENE
-40,700
Closed -$30.5K
GENE
15753
DELISTED
Genetic Technologies Ltd.
GENE
-682
Closed -$510
STAF
15754
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
-11,576
Closed -$16.1K
VRPX
15755
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
-1,255
Closed -$21.8K
BPTH
15756
DELISTED
Bio-Path Holdings Inc
BPTH
-10,917
Closed -$9.93K
CYTO
15757
DELISTED
Altamira Therapeutics Ltd
CYTO
-14,802
Closed -$9.35K
BIOR
15758
CALL
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
-990
Closed -$4.97K
BIOR
15759
PUT
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
-30
Closed -$150
XELA
15760
CALL
DELISTED
Exela Technologies, Inc. Common Stock
XELA
-1,200
Closed -$2.47K
XELA
15761
DELISTED
Exela Technologies, Inc. Common Stock
XELA
-24,135
Closed -$49.7K
XELA
15762
PUT
DELISTED
Exela Technologies, Inc. Common Stock
XELA
-1,600
Closed -$3.3K
ARCH
15763
DELISTED
Arch Resources, Inc.
ARCH
-5,289
Closed -$804K
ARC
15764
CALL
DELISTED
ARC Document Solutions, Inc.
ARC
-11,900
Closed -$40.2K
ARC
15765
DELISTED
ARC Document Solutions, Inc.
ARC
-15,563
Closed -$52.6K
ARC
15766
PUT
DELISTED
ARC Document Solutions, Inc.
ARC
-10,700
Closed -$36.2K
EMKR
15767
CALL
DELISTED
Emcore Corp
EMKR
-19,700
Closed -$43.5K
EMKR
15768
PUT
DELISTED
Emcore Corp
EMKR
-8,000
Closed -$17.7K
LBPH
15769
CALL
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
-12,300
Closed -$410K
LBPH
15770
PUT
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
-13,900
Closed -$463K
VSTO
15771
CALL
DELISTED
Vista Outdoor Inc.
VSTO
-99,000
Closed -$3.88M
VSTO
15772
DELISTED
Vista Outdoor Inc.
VSTO
-53,275
Closed -$2.09M
VSTO
15773
PUT
DELISTED
Vista Outdoor Inc.
VSTO
-35,200
Closed -$1.38M
VZIO
15774
CALL
DELISTED
VIZIO Holding Corp.
VZIO
-9,600
Closed -$107K
VZIO
15775
DELISTED
VIZIO Holding Corp.
VZIO
-216,966
Closed -$2.42M

Similar funds

Ken Griffin's Q4 2024 Portfolio in Review

As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.

  • Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
  • Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
  • Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
  • Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
  • Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
  • Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.